Novel COVID-19 biomarkers identified through multi-omics data analysis: N-acetyl-4-O-acetylneuraminic acid, N-acetyl-L-alanine, N-acetyltriptophan, palmitoylcarnitine, and glycerol 1-myristate.

Autor: de Fátima Cobre A; Universidade Federal do Paraná, Curitiba, Brazil., Alves AC; School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK., Gotine ARM; Public Health College, Universidade de São Paulo, São Paulo, Brazil., Domingues KZA; Universidade Federal do Paraná, Curitiba, Brazil., Lazo REL; Universidade Federal do Paraná, Curitiba, Brazil., Ferreira LM; Department of Pharmacy, Universidade Federal do Paraná, Campus III, Av. Pref. Lothário Meissner, 632, Jardim Botânico, Curitiba, PR, 80210-170, Brazil., Tonin FS; H&TRC - Health & Technology Research Centre, ESTeSL, Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Lisbon, Portugal., Pontarolo R; Department of Pharmacy, Universidade Federal do Paraná, Campus III, Av. Pref. Lothário Meissner, 632, Jardim Botânico, Curitiba, PR, 80210-170, Brazil. pontarolo@ufpr.br.

Publikováno v: Internal and emergency medicine [Intern Emerg Med] 2024 Aug; Vol. 19 (5), pp. 1439-1458. Date of Electronic Publication: 2024 Feb 28.

Methodological quality and clinical recommendations of guidelines on the management of dyslipidaemias for cardiovascular disease risk reduction: a systematic review and an appraisal through AGREE II and AGREE REX tools.

Autor: Deffert F; Pharmaceutical Sciences Postgraduate Program, Universidade Federal do Paraná, Av. Pref. Lothário Meissner, 632, Jardim Botânico, Curitiba, PR 80210-170, Brazil., Vilela APO; Pharmaceutical Assistance Postgraduate Program, Universidade Federal do Paraná, Av. Pref. Lothário Meissner, 632, Jardim Botânico, Curitiba, PR 80210-170, Brazil., Cobre AF; Pharmaceutical Sciences Postgraduate Program, Universidade Federal do Paraná, Av. Pref. Lothário Meissner, 632, Jardim Botânico, Curitiba, PR 80210-170, Brazil., Furlan LHP; Health Technology and Value Based Health Evaluation Sector, Unimed Paraná, Curitiba, Brazil., Tonin FS; Pharmaceutical Sciences Postgraduate Program, Universidade Federal do Paraná, Av. Pref. Lothário Meissner, 632, Jardim Botânico, Curitiba, PR 80210-170, Brazil.; Pharmaceutical Assistance Postgraduate Program, Universidade Federal do Paraná, Av. Pref. Lothário Meissner, 632, Jardim Botânico, Curitiba, PR 80210-170, Brazil.; H&TRC - Health & Technology Research Center, ESTeSL - Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Avenida D. João II, Lote 4.69.01, Parque das Nações, Lisboa 1990-096, Portugal., Fernandez-Lllimos F; Applied Molecular Biosciences Unit (UCIBIO), Institute for Health and Bioeconomy (i4HB), Laboratory of Pharmacology Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto 4050-313, Portugal., Pontarolo R; Pharmaceutical Sciences Postgraduate Program, Universidade Federal do Paraná, Av. Pref. Lothário Meissner, 632, Jardim Botânico, Curitiba, PR 80210-170, Brazil.; Pharmaceutical Assistance Postgraduate Program, Universidade Federal do Paraná, Av. Pref. Lothário Meissner, 632, Jardim Botânico, Curitiba, PR 80210-170, Brazil.

Publikováno v: Family practice [Fam Pract] 2024 Oct 08; Vol. 41 (5), pp. 649-661.

In silico approaches supporting drug repurposing for Leishmaniasis: a scoping review.

Autor: Scheiffer G; Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, Paraná, Brazil., Domingues KZA; Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, Paraná, Brazil., Gorski D; Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, Paraná, Brazil., Cobre AF; Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, Paraná, Brazil., Lazo REL; Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, Paraná, Brazil., Borba HHL; Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, Paraná, Brazil., Ferreira LM; Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, Paraná, Brazil., Pontarolo R; Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, Paraná, Brazil.

Publikováno v: EXCLI journal [EXCLI J] 2024 Sep 03; Vol. 23, pp. 1117-1169. Date of Electronic Publication: 2024 Sep 03 (Print Publication: 2024).

Methodological Quality of Pulmonary Arterial Hypertension Treatment Evidence-Based Guidelines: A Systematic Review Using the AGREE II and AGREE REX Tools.

Autor: Vilela APO; Pharmaceutical Assistance Postgraduate Program, Federal University of Paraná, Curitiba, Brazil., Deffert F; Pharmaceutical Sciences Postgraduate Program, Universidade Federal Do Paraná, Curitiba, Brazil., Lucchetta RC; Health Technology Assessment Unit, Oswaldo Cruz German Hospital, São Paulo, Brazil., da Silva Pires YM; Pharmaceutical Sciences Postgraduate Program, Federal University of Paraná, Curitiba, Brazil., Mainka FF; Pharmaceutical Sciences Postgraduate Program, Federal University of Paraná, Curitiba, Brazil., Tonin FS; Pharmaceutical Sciences Postgraduate Program, Federal University of Paraná, Curitiba, Brazil. fernanda.tonin@estesl.ipl.pt.; H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. Dom João II Lote 4.69 01, 1990-096, Lisbon, Portugal. fernanda.tonin@estesl.ipl.pt., Pontarolo R; Department of Pharmacy, Federal University of Paraná, Curitiba, Brazil.

Publikováno v: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2024 Jul 09. Date of Electronic Publication: 2024 Jul 09.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.